ArticleAnalytical chemistry2025
Machine Learning-Assisted False Positive Detection in Metabolite Identification Workflows.
Article in Analytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metabolite identification is a pivotal step in drug discovery and development, enabling the comprehensive analysis of drug-derived compounds within biological systems. However, the complexity of liquid chromatography-mass spectrometry data often results in numerous false positives, complicating the identification of true metabolites. This study introduces a machine-learning-based approach to improve the accuracy of false positive detection in metabolite identification workflows. By incorporating expert knowledge, we develop a feature set for metabolite-related chromatographic peaks that characterizes true and false positives with high accuracy, integrating data from mass spectra, chromatographic signals, and kinetic profiles. We validate this method via gradient boosting decision tree classifiers on both publicly available and proprietary "real-world" data sets, including small molecules and new modalities. Our findings demonstrate that machine learning-assisted techniques significantly reduce false positive identifications, thereby increasing the efficiency and accuracy of metabolite identification processes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.